We are live on ! Find out more
Nicholas Company

Nicholas Company Portfolio holdings

AUM $5.47B Turnover 6.8%
1-Year Est. Return 16.96%
This Fund
S&P 500
This Quarter Est. Return
+3.14%
1 Year Est. Return
+16.96%
3 Year Est. Return
+65.72%
5 Year Est. Return
+94.16%
10 Year Est. Return
+404.17%
AUM
$5.35B
AUM Growth
+$68.6M
Cap. Flow
+$11.9M
Cap. Flow %
0.22%
Top 10 Hldgs %
28.82%
Holding
225
New
11
Increased
66
Reduced
54
Closed
15
Avg Time Held
1.9 years
Top 10 Avg Time Held
1.8 years
Top 20 Avg Time Held
1.4 years

Top Buys

Rank Stock Value
1
IBM icon
IBM
IBM
+$123M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$33.5M
3
PARA icon
Paramount Global Class B
PARA
+$32.1M
4
BHC icon
Bausch Health
BHC
+$24.1M
5
PFE icon
Pfizer
PFE
+$21M

Top Sells

Rank Stock Value
1
KMI icon
Kinder Morgan
KMI
+$91.8M
2
MCD icon
McDonald's
MCD
+$82.7M
3
CAB
Cabela's Inc
CAB
+$64.2M
4
ORCL icon
Oracle
ORCL
+$43.2M
5
MSFT icon
Microsoft
MSFT
+$41.6M

Sector Composition

Rank Sector Weight
1 Healthcare 28.05%
2 Industrials 19.5%
3 Consumer Discretionary 14.62%
4 Financials 11.15%
5 Communication Services 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
WPP icon
76
WPP
WPP
$5.88B
$10.5M 0.2%
91,170
+100
+0.1% +$11.3K
2014 Q3
5 quarters
IEX icon
77
IDEX
IEX
$17.4B
$10.3M 0.19%
133,865
– –
2013 Q2
10 quarters
IMS
78
DELISTED
IMS HEALTH HLDGS INC COM STK (DE)
IMS
$9.95M 0.19%
390,710
+347,110
+796% +$9.7M
2015 Q3
1 quarter
RJF icon
79
Raymond James Financial
RJF
$30.2B
$9.86M 0.18%
255,240
– –
2013 Q2
10 quarters
GPN icon
80
Global Payments
GPN
$22.1B
$9.85M 0.18%
152,635
-17,515
-10% -$1.18M
2015 Q1
3 quarters
CHKP icon
81
Check Point Software Technologies
CHKP
$14.1B
$9.67M 0.18%
118,825
-27,700
-19% -$2.3M
2013 Q2
10 quarters
FISV icon
82
Fiserv Inc
FISV
$25.3B
$9.32M 0.17%
203,928
-4,420
-2% -$208K
2013 Q2
10 quarters
AVGO icon
83
Broadcom
AVGO
$1.57T
$9.08M 0.17%
625,750
-125,000
-17% -$1.62M
2013 Q2
10 quarters
TROW icon
84
T. Rowe Price
TROW
$21.5B
$9.06M 0.17%
126,795
+21,800
+21% +$1.6M
2013 Q2
10 quarters
EPD icon
85
Enterprise Products Partners
EPD
$79.5B
$8.95M 0.17%
+350,000
New +$9.09M
2015 Q4
0 quarters
RSG icon
86
Republic Services
RSG
$70.9B
$8.93M 0.17%
202,950
-1,000
-0.5% -$43.6K
2013 Q2
10 quarters
R icon
87
Ryder
R
$9.14B
$8.91M 0.17%
156,800
-95,995
-38% -$6.34M
2013 Q2
10 quarters
LUMN icon
88
Lumen Technologies, Inc. Common Stock
LUMN
$4.8B
$8.8M 0.16%
349,655
– –
2013 Q4
8 quarters
DNKN
89
DELISTED
Dunkin' Brands Group, Inc.
DNKN
$8.74M 0.16%
205,145
+25,000
+14% +$1.05M
2014 Q1
7 quarters
PRGO icon
90
Perrigo
PRGO
$2.31B
$8.52M 0.16%
58,850
+18,110
+44% +$2.79M
2013 Q2
10 quarters
NDSN icon
91
Nordson
NDSN
$18B
$8.35M 0.16%
130,105
+30,000
+30% +$2.06M
2014 Q3
5 quarters
RHT
92
DELISTED
Red Hat Inc
RHT
$8.29M 0.16%
100,100
– –
2013 Q2
10 quarters
MELI icon
93
Mercado Libre
MELI
$93B
$8.25M 0.15%
72,180
– –
2013 Q2
10 quarters
ENLK
94
DELISTED
EnLink Midstream Partners, LP
ENLK
$8.24M 0.15%
497,100
+19,695
+4% +$319K
2013 Q4
8 quarters
WAB icon
95
Wabtec
WAB
$48.4B
$8.19M 0.15%
115,105
– –
2013 Q2
10 quarters
WSM icon
96
Williams-Sonoma
WSM
$29.5B
$8.08M 0.15%
276,660
+2,400
+0.9% +$82.2K
2013 Q2
10 quarters
CDK
97
DELISTED
CDK Global, Inc.
CDK
$8.08M 0.15%
170,145
– –
2014 Q4
4 quarters
GEF.B icon
98
Greif Class B
GEF.B
$4.19B
$8.01M 0.15%
187,164
-115
-0.1% -$4.76K
2013 Q2
10 quarters
REGN icon
99
Regeneron Pharmaceuticals
REGN
$81.4B
$7.88M 0.15%
14,510
– –
2013 Q3
9 quarters
ORI icon
100
Old Republic International
ORI
$9.58B
$7.77M 0.15%
417,300
-351,885
-46% -$6.34M
2013 Q2
10 quarters
2 3
4
5 6

Similar funds

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
EFG International
EFG International Zurich $5.46B AUM
Antipodes Partners
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Exor N.V.
Exor N.V. Amsterdam, Netherlands $5.46B AUM 6.21% 1-Year Est. Return
Abrams Capital Management
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Voleon Capital Management
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
Glenview Capital Management
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
TD Private Client Wealth
TD Private Client Wealth New York $5.44B AUM 18.56% 1-Year Est. Return

Nicholas Company's Q4 2015 Portfolio in Review

As of Q4 2015, Nicholas Company held 225 positions worth $5.35B, up 1.3% from $5.28B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Nicholas Company's Q4 2015 filing shows 11 new, 66 increased, 54 reduced and 15 closed positions. Its largest new stake was IBM: 918,969 shares worth $121M. The largest sale was Kinder Morgan, an estimated $91.8M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 28% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Nicholas Company's largest Q4 2015 buy was IBM: 918,969 shares worth $121M.
  • Nicholas Company added most to Jazz Pharmaceuticals in Q4 2015, an estimated $33.5M increase.
  • Nicholas Company's biggest Q4 2015 reduction was Kinder Morgan, cutting an estimated $91.8M.
  • Nicholas Company fully exited Cabela's Inc in Q4 2015, selling an estimated $64.2M.
  • Nicholas Company's ten largest holdings make up 29% of its $5.35B portfolio in Q4 2015.
  • Nicholas Company opened 11 new positions and closed 15 in Q4 2015.
  • Nicholas Company's portfolio value rose 1.3% quarter-over-quarter to $5.35B.

Based on Nicholas Company's 13F filing for Q4 2015, filed 11 Feb 2016.